Publicaciones (26) Publicaciones de IGOR HORRILLO FURUNDARENA

2024

  1. Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain

    British Journal of Pharmacology

2023

  1. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects

    Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487

  2. Psilozibinaren administrazio akutuaren eraginen ebaluazioa garun kortexean serotonina, noradrenalina eta dopamina mailak neurtuz: garun-mikrodialisiaren bidez burututako ikerlana esna dauden saguetan

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

2022

  1. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

    Addiction Biology, Vol. 27, Núm. 6

  2. High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers

    International Journal of Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 468-478

  3. Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response

    Biomedicine and Pharmacotherapy, Vol. 154

2021

  1. Antisorgailu hormonalen garrantzi etiopatologiko eta soziala

    Osagaiz: osasun-zientzien aldizkaria, Vol. 5, Núm. 2, pp. 107-118

  2. Edari energetikoak eta haien eraginak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 41, pp. 83-96

  3. El rizoma de cúrcuma (Curcuma longa) en el tratamiento del síndrome metabólico

    Revista de fitoterapia, Vol. 19, Núm. 1, pp. 5-13

  4. Enfermedades mentales y nutrición saludable. Nuevas alternativas para su tratamiento

    Revista española de nutrición comunitaria = Spanish journal of community nutrition, Vol. 27, Núm. 1

2020

  1. Pimavanserin exhibits serotonin 5-HT2A receptor inverse agonism for Gαi1- and neutral antagonism for Gαq/11-proteins in human brain cortex

    European Neuropsychopharmacology, Vol. 36, pp. 83-89

  2. Serum β-endorphin levels are associated with addiction to suicidal behavior: A pilot study

    European Neuropsychopharmacology, Vol. 40, pp. 38-51

  3. Terapia antidepresiboaren azken pausoak: oraina eta geroa

    Osagaiz: osasun-zientzien aldizkaria, Vol. 4, Núm. 2, pp. 21-36

2019

  1. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus

    Neuropharmacology, Vol. 158

2018

  1. Depresioaren teoria neuroinflamatorioa

    Osagaiz: osasun-zientzien aldizkaria, Vol. 2, Núm. 1, pp. 7-20

2017

  1. Droga berriak merkatu berritzailean

    Osagaiz: osasun-zientzien aldizkaria, Vol. 1, Núm. 1, pp. 6-15

2016

  1. Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study

    Psychopharmacology, Vol. 233, Núm. 23-24, pp. 3861-3867

2013

  1. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain

    European Journal of Pharmacology, Vol. 709, Núm. 1-3, pp. 13-19

  2. Chronic pain leads to concomitant noradrenergic impairment and mood disorders

    Biological Psychiatry, Vol. 73, Núm. 1, pp. 54-62

  3. Kannabisaren terapia erabilera

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 1, pp. 99-113